Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Controlled Human Infection Study of a Recombinant H3N2 (A/Texas/71/2017, Clade 3C3a) Influenza Virus in Healthy Adults in Australia

NCT06972810 is registered in ClinicalTrials.gov with University of Melbourne as lead sponsor.

NCT NCT06972810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06972810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Controlled Human Infection Study of a Recombinant H3N2 (A/Texas/71/2017, Clade 3C3a) Influenza Virus in Healthy Adults in Australia
Lead sponsor
University of Melbourne
Phase
Not applicable
Overall status
Completed
Start date
May 5, 2025
Completion date
November 26, 2025
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza